Sweden is experiencing a significant shortage of estrogen medication, impacting women undergoing menopause. This scarcity forces patients to actively monitor deliveries, seek medication from abroad, and endure long waits at pharmacies, sometimes traveling considerable distances. The situation has prompted concerns about access to essential healthcare for women experiencing menopausal symptoms. Writer Maria Sveland highlights the difficulties and questions why quality of life for women is not considered a fundamental medical right. The shortage is causing distress and disruption for those reliant on hormone replacement therapy to manage their health. Authorities have not yet provided a comprehensive solution to the ongoing supply issues.